Article
The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance
2023-04-21
Abstract excerpt
<title>Abstract</title> <p>Background Nowadays, the incidence rate of advanced prostate cancer at the first time of diagnosis grows higher in China yearly. At present, androgen deprivation therapy is the standard first-line treatment of advanced prostate cancer. However, after several years of ADT, most patients will inevitably progress to castration-resistant prostate cancer (CRPC). Previous studies mainly focus...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a4f0db3-99cd-5209-ab2a-3d105ec0d2ac
- DOI
- 10.21203/rs.3.rs-2779941/v1
